elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
samarium-153 therapy
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Application
keyword
samarium-153 therapy
RIS
0.000
(Research Intensity Score)
Papers
4
Top papers
Samarium-153 therapy for prostate cancer: the evaluation of urine activity, staff exposure and dose rate from patients
2014 · 13 citations
Samarium-153 Therapy and Radiation Dose for Prostate Cancer
2016 · 6 citations
Lactate dehydrogenase (LDH) as predictive factor of the pain free syndrome duration after radionuclide treatment of bone metastases in patients with breast cancer
2016
Bone marrow scan to assess functional reserve and predict severity and duration of neutropenia and thrombocytopenia following Samarium-153 therapy
2006
Newest papers
Samarium-153 Therapy and Radiation Dose for Prostate Cancer
2016 · 6 citations
Lactate dehydrogenase (LDH) as predictive factor of the pain free syndrome duration after radionuclide treatment of bone metastases in patients with breast cancer
2016
Samarium-153 therapy for prostate cancer: the evaluation of urine activity, staff exposure and dose rate from patients
2014 · 13 citations
Bone marrow scan to assess functional reserve and predict severity and duration of neutropenia and thrombocytopenia following Samarium-153 therapy
2006
A sample from the 4 top papers behind samarium-153 therapy.
Create a free account to browse them all →
samarium-153 therapy's history
Research intensity over time
Explore samarium-153 therapy's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
samarium-153 therapy's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link